Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bio-Techne Corp - Common Stock (NQ:TECH)

49.15 +0.91 (+1.89%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bio-Techne Corp - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Earnings Scheduled For February 1, 2024
Companies Reporting Before The Bell • ING Groep (NYSE:ING) is expected to report earnings for its fourth quarter. • Shell (NYSE:SHEL) is likely to report quarterly earnings at $1.81 per share on... 
Via Benzinga
Earnings Outlook For Bio-Techne
Via Benzinga
3 Top-Rated Biotech Stocks Wall Street Analysts Are Loving Now: January 2024
These top-rated biotech stocks are going to be in high demand in January and in every other month in 2024. 
Via InvestorPlace
Expert Ratings for Bio-Techne
Via Benzinga
Advancing with Stability: Bio-Techne Benefits Investors with Growing Earnings and Stable Payouts
By the close of today, November 24, 2023, Bio-Techne (NASDAQ:TECH) will issue a dividend payout of $0.08 per share, resulting in an annualized dividend yield of 0.56%. Only those investors who owned... 
Via Benzinga
Earnings Preview: Bio-Techne
Via Benzinga
3 AI Stock-Split Stocks to Buy Now
Traditional stock splits don’t happen very often. AI stock splits are even rarer. Here are three possibilities. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Healthcare Stocks to Keep an Eye On
These three lesser-known healthcare companies have strong growth potential. 
Via The Motley Fool
Bio-Techne's Ex-Dividend Date Is Thursday, Here's What You Need To Know
Via Benzinga
Nurturing Growth: Bio-Techne Supports Investors with Growing Earnings
Via Benzinga
This Favorable Sign Appears On Bio-Techne's Chart
Via Benzinga
What 4 Analyst Ratings Have To Say About Bio-Techne
Via Benzinga
Earnings Scheduled For October 31, 2023
Companies Reporting Before The Bell • BBVA (NYSE:BBVA) is likely to report earnings for its third quarter. • BP (NYSE:BP) is expected to report quarterly earnings at $1.37 per share on revenue of... 
Via Benzinga
3 Healthcare Stocks That Should Be on Every Investor’s Radar This Fall
The beauty of healthcare stocks is that they tend to do well in most economic conditions because you can’t live without them. 
Via InvestorPlace
Life Science Firm Bio-Techne's Success Formula: Astute Acquisitions Offering Transformation
William Blair has initiated coverage on coverage of Bio-Techne Corp (NASDAQ: TECH) with a 
Via Benzinga
Bio-Techne: Q3 Earnings Insights
Via Benzinga
Thursday Is Your Last Chance To Buy Bio-Techne Before The Dividend Payout
Via Benzinga
Analyst Expectations for Bio-Techne's Future
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 369 companies set new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
Via Benzinga
Earnings Outlook For Bio-Techne
Via Benzinga
3 Biotech Stocks to Buy Before the Breakout
Explosive growth and rapid innovation lie ahead for these three biotechnology stocks, making them the ones to watch. 
Via InvestorPlace
Bio-Techne's Acquisition of Lunaphore Expands Its Spatial Biology Offerings
Bio-Techne Corporation (NASDAQ: TECH) has agreed to acquire Lunaphore Inc with  
Via Benzinga
Lunaphore to Get Acquired by Bio-Techne
From Lunaphore
Via Business Wire
Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation
RBC Capital Markets has downgraded Abcam PLC (NASDAQ: ABCM) from Outperform to Sector Perform with a price target of $22,  
Via Benzinga
This Analyst With 83% Accuracy Rate Sees Around 11% Upside In Texas Roadhouse - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
U.S stocks closed higher on Friday, with the Dow Jones jumping more than 500 points during the session. 
Via Benzinga
7 Biotech Stocks That Could Cure Your Portfolio Woes
If you want to revitalize your portfolio with some exciting opportunities, these biotech stocks to buy might fit the bill. 
Via InvestorPlace
5 Cheapest Health Care Stocks You Should Think About
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
5 Health Care Stocks That Are Diving - And May Rally
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2023
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.